Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy
G-POEM
2 other identifiers
interventional
40
1 country
1
Brief Summary
The objective of the study is to document the clinical efficacy and complications of endoscopic pyloromyotomy in patients with refractory gastroparesis (diabetic, post-operative and idiopathic), compared to Botulinic toxin injection intra-pyloric the results of which are close to the placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Nov 2016
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2016
CompletedFirst Posted
Study publicly available on registry
October 7, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedOctober 18, 2016
October 1, 2016
2.8 years
October 6, 2016
October 17, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Gastroparesis Cardinal Symptom Index score calculation
Up to 3 months
Study Arms (2)
Per-oral Endoscopy Pyloromyotomy (G-POEM)
EXPERIMENTALIntrapyloric injection of botulinum toxin
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Older than 18 years.
- Presenting a clinical refractory gastroparesis for\> 1 year, that is to say whose functional nonspecific symptoms persisting despite medical therapy (prokinetic) optimal.
- No history of gastric surgery (partial gastrectomy Sleeve gastrectomy, ...) or esophageal surgery
- Not having endoscopic gastric lesions (ulcers antro-pyloric cancer).
- Having no indication against anesthetic.
- Having consented to participate in the study.
- Affiliated with a social security scheme (beneficiary or assignee).
You may not qualify if:
- Minors.
- Pregnant or breastfeeding
- Having an anesthetic against indication.
- Scan the normal gastric emptying
- Under curative dose anticoagulants whose suspension is inappropriate.
- Under dual anti-platelet aggregation whose suspension is inappropriate.
- Being unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gastro-entérologie, Hôpital Nord ,Assistance Publique Hôpitaux de Marseille
Marseille, 13015, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Catherine Geindre
Assistance Publique Hôpitaux de Marseille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2016
First Posted
October 7, 2016
Study Start
November 1, 2016
Primary Completion
September 1, 2019
Study Completion
March 1, 2020
Last Updated
October 18, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share